To explore the larger immunological impacts of an NKG2A+ bias, we assigned each patient with lupus and each healthy donor as NKG2A+ or NKG2C+ biased based on their ratio of NKG2A+ and NKG2C+ CD8+ cells (see STAR Methods). This evidence concerns the gene CD8A and systemic lupus erythematosus.